BRIEF-Veru Enters Clinical Supply Agreement With Novo Nordisk For Phase 2B Plateau Study - SEC Filing

Veru Inc

Veru Inc

VERU

0.00

June 4 (Reuters) - Veru Inc VERU.O:

  • VERU - ENTERS CLINICAL SUPPLY AGREEMENT WITH NOVO NORDISK FOR PHASE 2B PLATEAU STUDY - SEC FILING

  • VERU - NOVO NORDISK TO SUPPLY WEGOVY AT NO CHARGE FOR VERU PHASE 2B STUDY - SEC FILING

  • VERU - TO PROVIDE NOVO NORDISK WITH INSIGHTS AND UPDATES ON OBESITY TRIAL DESIGN - SEC FILING

  • VERU - GRANTS NOVO NORDISK RIGHT OF FIRST NEGOTIATION FOR ENOBOSARM IN COMBINATION WITH ANY NOVO'S GLP-1 PRODUCTS

Source text: [ID:n0001437749-26-019478]

Further company coverage: VERU.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.